Current Research Projects Using ChronoRecord For Data Collection

M Bauer¹, J Kiermeir, K Neuhaus, R Ricken, K Wiethoff, T Glenn, S Priebe.

Effectiveness of a new program of group psychoeducation and computer based daily charting in bipolar disorder - multicenter randomized controlled trial. 75 patients will receive the experimental intervention and 75 the control intervention.

M Bauer¹, N Rasgon, P Grof, T Bschor, T Glenn, PC Whybrow

Investigation of the relationship between mood and sleep in patients with bipolar disorder using a time-series approach.

R Munoz²

Comparison of the efficacy of duloxetine in Hispanic and non-Hispanic white patiets with major depression over a 6 month period. ChronoRecord will be used for secondary outcome measures - daily mood and medication compliance (Lilly funded study).

N Rasgon³, C Bowden, T Ketter, V Singh

Assesment of the impact of lamotrigine on the reproductive function of 60 women with bipolar disorder over 6 months (sponsored by GlaxoSmithKline).

W Marsh, N Rasgon³

Investigation of the relation between mood and menstral cycle in women with bipolar disorder.

M Alda⁴ (Principal Investigator)

Double-blind crossover study of methylene blue for cognitive dysfunction in 60 patients with bipolar disorder.

J Scott⁵, N Ferrier⁶, Y Malliaris⁷ and MDF The Bipolar Organization

The MRC London/Newcastle eMonitoring Trial: Electronic Monitoring of Symptom Variability in Bipolar Disorders. For further information about the project, visit our website www.bipolarlab.com.

A Suwalska⁸ (Principal Investigator)

Investigation of mood and sleep patterns in healthy young adults.

JK Rybakowski⁹, A Suwalska⁸ (Principal Investigators)

Validation of Polish version of ChronoRecord in patients with mood disorders.

G Murray¹⁰, F Judd

Investigation if changes in daily mood, sleep and activity levels can predict relapse into episodes of mania or depression in patients with bipolar disorder over 12 months. Activity will be measured by actigraph.

¹ Michael Bauer, MD, PhD, Technische Universität, Dresden, Germany.

² Rodrigo Munoz, MD, University of California, San Diego.

³ Natalie Rasgon, MD, PhD, Stanford School of Medicine, Palo Alto, CA.

⁴ Martin Alda, MD, McGill University, Montreal, QC Canada.

⁵ Jan Scott, MD, PhD, Institute of Psychiatry, Kings’ College, London, UK.

⁶ Nicol Ferrier, MD, PhD, Institute of Neuroscience, Newcastle University, UK.

⁷ Yanni Malliaris, BSc (Hons), PhD Candidate, Institute of Psychiatry, Kings’ College, London, UK.

⁸ Alexandra Suwalska, MD, Karol Marcinkowski University of Medical Science, Poznan, Poland.

⁹ Janusz K. Rybakowski, MD, Karol Marcinkowski University of Medical Science, Poznan, Poland.

¹⁰ Greg Murray, PhD, Swinburne University of Technology, Melbourne, Austraila.